Phase 2 clinical trial results show potential to shorten TB treatment time
Sorfequiline, previously known as TBAJ-876, was evaluated in combination with pretomanid and linezolid in a randomized, controlled trial in people with drug-sensitive TB Reports and Proceedings TB Alliance COPENHAGEN (November 19, 2025)—New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), […]
Phase 2 clinical trial results show potential to shorten TB treatment time Read More »
